FIRST AMERICAN HEALTH CONCEPTS INC
10KSB40, 1998-10-28
BUSINESS SERVICES, NEC
Previous: FIRST AMERICAN HEALTH CONCEPTS INC, PRER14A, 1998-10-28
Next: BEAR STEARNS COMPANIES INC, 424B3, 1998-10-28



                                  UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                   FORM 10-KSB

[X]      Annual  Report  Pursuant  to  Section  13 or  15(d)  of the  Securities
         Exchange  Act of 1934.  For the fiscal  year August 1, 1997 to July 31,
         1998.

[ ]      Transition  Report  Pursuant to Section 13 or 15(d) of the Securities
         Exchange Act of 1934. For the transition period from N/A to N/A .

Commission File Number:  0-15207

                      FIRST AMERICAN HEALTH CONCEPTS, INC.
                 (Name of small business issuer in its charter)

          ARIZONA                                       86-0418406
(State of Incorporation)                    (IRS Employer Identification Number)

7776 SOUTH POINTE PARKWAY WEST, SUITE 150, PHOENIX, ARIZONA           85044-5424
        (Address of principal executive offices)                      (Zip Code)

                                 (602) 414-0300
                (Issuer's telephone number, including area code)

           SECURITIES REGISTERED PURSUANT TO SECTION 12(B) OF THE ACT:
                                      NONE

           SECURITIES REGISTERED PURSUANT TO SECTION 12(G) OF THE ACT:
                         Common Stock without par value
                                (Title of class)

Check  whether the issuer (1) filed all reports  required to be filed by Section
13 or 15(d) of the  Exchange  Act during the past 12 months (or for such shorter
period that the registrant was required to file such reports),  and (2) has been
subject to such filing requirements for the past 90 days. Yes [X]  No [ ]

Check if there is no disclosure of delinquent  filers in response to Item 405 of
Regulation  S-B is not  contained  in  this  form,  and no  disclosure  will  be
contained,  to the  best of  Registrant's  knowledge,  in  definitive  proxy  or
information statements incorporated by reference in Part III of this Form 10-KSB
or any amendment to this Form 10-KSB. [X]

Issuer's revenue for the fiscal year ended July 31, 1998 was $7,809,122.

Registrant's  Common Stock  outstanding at October 22, 1998 was 2,604,736 shares
after  deducting  468,102 shares of treasury  stock. At such date, the aggregate
market value of Registrant's Common stock held by non-affiliates, based upon the
closing  price  at  which  such  stock  was  sold on  NASDAQ  on such  date  was
approximately $5,336,476.

                       DOCUMENTS INCORPORATED BY REFERENCE
Portions of  Registrant's  definitive  Proxy Statement for the Annual Meeting of
Shareholders to be held on December 11, 1998 are incorporated in Part III as set
forth herein.
<PAGE>
                                TABLE OF CONTENTS

PART I                                                                      PAGE

Item 1.   Description of Business                                            3
Item 2.   Desciption of Property                                             6
Item 3.   Legal Proceedings                                                  6
Item 4.   Submission of Matters to a Vote of Security Holders                6

PART II

Item 5.   Market for Common Equity and Related Stockholder Matters           7
Item 6.   Management's Discussion and Analysis                               7
Item 7.   Financial Statements                                              11
Item 8.   Changes in and Disagreements with Accountants on Accounting and
          Financial Disclosure                                              11

PART III

Item 9.   Directors, Executive Officers, Promoters and Control Persons;
          Compliance with Section 16 (a) of the Exchange Act                12
Item 10.  Executive Compensation                                            13
Item 11.  Security Ownership of Certain Beneficial Owners and Management    13
Item 12.  Certain Relationships and Related Transactions                    13
Item 13.  Exhibits and Reports on Form 8-K                                  13

SIGNATURES                                                                  14


                                       2
<PAGE>
PART I
FIRST AMERICAN HEALTH CONCEPTS, INC.

ITEM 1.  DESCRIPTION OF BUSINESS

BUSINESS DEVELOPMENT

         First  American  Health  Concepts,  Inc.  ("FAHC" or the "Company") was
incorporated  in Arizona in 1981 and first  offered  common  stock  publicly  in
October  1985.  FAHC  markets and  administers  vision care  programs  under the
registered trade names of Eye Care Plan of America(R) and ECPA(R).

         In  seventeen  (17)  years,  ECPA has grown  steadily,  developing  and
marketing   directed  and  managed  vision  care  programs  for  businesses  and
organizations nationwide.  Initially, ECPA's growth came from the development of
a direct  access  preferred  pricing  program  (ECPA  Access)  that today is the
nation's largest  membership-based  vision care savings program. This program is
delivered through a national preferred provider (PPO) network of independent and
retail optometrists, opticians and ophthalmologists.  Through this same national
network,  ECPA has offered insured and self-funded  managed vision care products
(ECPA Select) since 1993.

         The expansion  from directed  vision savings  programs to  full-benefit
managed  vision care  required a  multi-year  investment  in  infrastructure  to
support the delivery of comprehensive benefits and claims  administration.  With
this  infrastructure  in place,  ECPA now  provides  paperless  vision care with
automated, 24-hour access to benefits and provider information.  This past year,
First American Health  Concepts,  Inc.  created a captive  reinsurance  company,
First  American   Reinsurance   Company,   (FARC),  that  will  provide  greater
flexibility and profit potential for ECPA's product offerings.

ECPA'S COMPETITIVE ADVANTAGE

         ECPA  delivers a better value in vision care  through a  "right-sized,"
accessible  provider  network that offers a diverse  choice of  independent  and
retail providers as well as an unlimited  selection of eyewear  materials.  ECPA
directs  members to a select group of providers in every  market,  and, with the
prospect of increased  patient volume,  providers  agree to a uniform  preferred
pricing  schedule  that is  significantly  below  retail  prices.  Three in five
Americans  prefer an  independent  vision care  provider.  ECPA's network of all
three Os -  optometrists,  ophthalmologists  and  opticians  is comprised of 61%
independent providers and 39% providers in retail chains.

         ECPA's competitive  advantage - diverse choice and real value with easy
access to benefits through paperless,  automated administration - positions ECPA
as a leader in a growing market for group vision care benefits.

ECPA PRODUCTS

*  ECPA ACCESS

                  ECPA Access is a direct  access  vision care savings  program.
         Members  are  provided a  membership  card and a list of the 10 closest
         providers.  In addition, they also may locate a nearby ECPA provider by
         calling the  toll-free  provider  locator  number on the card.  Members
         access providers directly and receive significant savings whenever they
         or their  dependents  present  their card,  regardless of the amount or
         frequency of purchases.

                                       3
<PAGE>
*  ECPA SELECT

                  ECPA Select  includes  full-benefit  insured  and  self-funded
         group vision care.  Members receive an ECPA membership card,  materials
         and a schedule of benefits,  including  out-of-network  benefits,  that
         varies by the plan  design  selected.  Members  call  ECPA's  toll-free
         provider  locator line to locate a nearby ECPA  provider,  and they are
         also  able to call  this  same  toll-free  line at any time to check on
         their benefits.  Members  schedule and access ECPA providers  directly.
         Members pay only a copayment, if applicable,  for scheduled vision care
         benefits.  After these scheduled benefits are exhausted,  members still
         have access to ECPA  preferred  pricing for direct  purchases  any time
         they present their card to any ECPA Provider.

                  Insured  benefits are  underwritten by Security Life Insurance
         Company of America  (founded in 1956,  Minnetonka,  Minnesota)  and The
         MEGA Life and Health Insurance Company (founded in 1982, Oklahoma City,
         Oklahoma).

A CHANGING MARKET AND GROWING DEMAND

         ECPA is able to deliver attractive, flexible and profitable vision care
to businesses large and small at a time when more and more Americans need vision
care and more companies are adding vision care  benefits.  Sixty (60) percent of
the American  population,  approximately 160.8 million people,  require a vision
correction,  according  to an optical  industry  report  published by the Jobson
Optical Group in 1998. An aging  population  means that the percent of Americans
who require a vision  correction,  for many years a constant  proportion  of the
U.S. population, is increasing and will continue to increase.

         Vision care is becoming more of a mainstream  employee  benefit.  Today
more than 50 percent of large employers (500 + employees) offer a vision benefit
to their  employees.  While  continued  growth is expected  in the large  market
segment,  the strongest growth is expected among smaller companies,  the largest
and fastest growing segment of the economy. For smaller companies to effectively
compete for talent,  they must strive to match the kinds of benefits  offered by
larger employers, including ancillary benefits such as vision care.

         One of the least expensive employee benefits, vision care was among the
most highly valued by employees in a recent national survey.  Many employees are
more  likely to visit  their  vision  care  provider  than  their  primary  care
physician.  And,  because a  low-cost,  routine eye exam can detect more than 50
serious medical conditions such as diabetes, many employers are beginning to see
vision  care  not  only as a  potential  boost  to  productivity,  but also as a
cost-saving wellness benefit.

         Healthy vision is everyone's business.

MEETING MARKET DEMAND

         ECPA  recognizes  significant  growth  potential  for vision care among
smaller businesses and has prepared to meet this market challenge. Marketing and
delivering  vision care to small  businesses  presents  two primary  challenges.
First,  a  greater  number of unit  sales  are  essential  to  increasing  total
membership growth, and as importantly, growth in total membership and unit sales
means a  greater  number  of  groups  to be set up and  administered.  While one
solution  might be to add  staff to  handle  the  increased  number of sales and
administrative  transactions,  this approach would not meet ECPA's commitment to
continual improvement in performance and productivity.

         ECPA will  manage an  increase  in sales  transactions  by  utilizing a
broker  distribution  strategy for ECPA Select sales and outbound  telemarketing
for ECPA Access sales.  Smaller

                                       4
<PAGE>
businesses  often rely on brokers  and agents who know their  needs best and can
find the right package of benefits for them.  ECPA has installed the appropriate
sales  incentives  and has  established  communications  and sales  support  for
successful product distribution.  In addition,  ECPA has established an outbound
telemarketing  function  to sell ECPA  Access to groups  with  fewer  than 1,000
employees.

         An increase in sales transactions also has required  fundamental change
in ECPA  operations.  With an  increase in the number of groups to be set up and
administered,  ECPA  has  focused  on work  process  flow  analysis  in order to
streamline and standardize operational processes and procedures.

EFFECTIVE AND EFFICIENT MANAGED VISION CARE INFORMATION

         EPCA is  able  to  manage  an  increase  in  sales  and  administration
transactions  because  of an  efficient  infrastructure.  A  key  part  of  this
infrastructure is ECPA's managed vision care information  system,  developed and
installed over the past few years. ECPA was the first company  nationally with a
vision care  application of the Health Systems Design (HSD)  Integrated  Managed
Care  System.  This new  system,  one of the  most  comprehensive  managed  care
information  systems  available,  allows ECPA to provide  paperless  vision care
benefits  administration  and  manage a  significant  increase  in the number of
administrative   transactions  for  group  installation  without  a  significant
increase in staffing or other operational costs.

         In  addition,  ECPA's  HSD  system  continues  to  produce  significant
improvements in  productivity.  This past year, the first full year in which the
HSD system has  managed the claims  processing  function  for ECPA,  the average
turnaround time for adjudicated claims was reduced by more than half. While this
system allows ECPA to provide automated, paperless vision care benefits, it also
provides the capacity for tracking and manipulating  benefits data and providing
enhanced decision support.

ECPA'S PREFERRED PROVIDER NETWORK

         Today,  ECPA's  Preferred  Provider  Network  includes more than 14,000
providers in more than 7,000  locations  throughout the United States and Puerto
Rico.

         In response to the  preferences  of current and potential ECPA members,
ECPA made two  significant  changes to its  Provider  Network and  Provider  Fee
Schedule  this past year.  First,  ECPA brought one of the most  popular  retail
vision  chains,  LensCrafters,  into the ECPA  Provider  Network.  Although most
Americans still prefer an independent  vision care provider,  LensCrafters  adds
another  attractive  dimension to ECPA's  Provider  Network.  In addition,  ECPA
modified  its  Preferred  Pricing  Schedule  to make it easier  for  members  to
understand.  While the amount of savings provided has not changed,  the schedule
now is based on retail  rather  than  wholesale  prices,  making  it easier  for
members to understand their savings and shop more effectively.

ECPA PROVIDERS AND QUALITY MANAGEMENT

         Each ECPA provider is credentialed  through  independent primary source
verification by an NCQA-certified  agency. ECPA providers must agree to maintain
normal business hours,  offer a full selection of eyewear,  possess all licenses
required to practice in the state in which their operations take place, maintain
sufficient  professional liability insurance,  and adhere to standards set forth
in ECPA's Provider Manual and Quality Assurance Manual. A nominal  credentialing
fee  is  also  required,   and  each  provider  agrees  to  pay  a  periodic  or
transaction-based fee for ECPA's administration of the network.

                                       5
<PAGE>
         Each  approved  provider  agrees to provide  vision care  according  to
ECPA's  standards,  to charge ECPA members no more than ECPA's preferred pricing
for eyewear and to guarantee  the  services,  care and related  materials to the
members' satisfaction.

          ECPA maintains a comprehensive provider quality assurance program that
includes  recredentialing  every two years and  provider  profiling  that tracks
member  complaints  and  grievances,  member  and  provider  surveys  and random
`mystery patient' responses.

GROUP ADMINISTRATION

         ECPA markets its programs only to employers and other  sponsors  having
access to ten or more  employees,  clients or customers.  Existing and potential
sponsors   include   employer   groups,    insurance   carriers,   third   party
administrators,  health  maintenance  organizations,  multiple  employer trusts,
financial  institutions,  associations,  labor unions,  governmental  bodies and
political subdivisions. Sponsors generally either pay an annual/monthly fee or a
monthly premium for each member enrolled.

ITEM 2.  DESCRIPTION OF PROPERTY

         The Company leases an aggregate of 15,000 square feet of Class B office
space for its sales  and  administrative  offices.  The  Company's  headquarters
office in Phoenix,  Arizona is leased at an effective  rate of $12,300 per month
with an  expiration  date of  September,  1999.  Sales  offices  are  located in
Atlanta,  Boston,  Columbus  (Ohio),  and Mesa (Arizona)  with  effective  rates
ranging from $456 to $895 per month and lease  expiration  dates through  April,
1999.

         The Company  maintains  cash  reserves for use in corporate  expansion,
financing growth of its business and general  corporate  purposes.  FACH invests
excess  cash  in  interest-bearing  securities  including  U.S.  Treasuries  and
municipal  obligations,  generally  with  maturities  of  less  than  one  year.
Investments  are governed by guidelines  established by a committee of the Board
of Directors and are generally not limited by type.

ITEM 3.  LEGAL PROCEEDINGS

         None

ITEM 4.  SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS

         None

                                       6
<PAGE>
PART II
FIRST AMERICAN HEALTH CONCEPTS, INC.

ITEM 5.  MARKET FOR COMMON EQUITY AND RELATED
STOCKHOLDER MATTERS

       Common                 Trading Range During the
       Stock Prices           Years Ended July 31,
                                     1998                1997
       ---------------------------------------------------------------

                               High     Low          High     Low
                              ---------------       ----------------
       Quarter Ended:
          October 31          $5       $2 7/8       $5 1/4   $3 7/8
          January 31          $5 1/2   $2 7/8       $4 3/4   $2 3/4
          April 30            $5       $3 1/4       $5       $1 3/4
          July 31             $5 1/4   $3 1/2       $4       $2 1/2

         Since February 27, 1995,  the Company's  common stock has traded on the
NASDAQ National Market System (symbol:  FAHC). Prior to that date, common shares
were traded on the NASDAQ Over-the-Counter Market. On October 5, 1998 there were
approximately  108  shareholders  of record,  not including those shares held in
street name.  The Company has neither  declared  nor paid any cash  dividends to
date and does not plan to do so in the immediate future.

ITEM 6.  MANAGEMENT'S DISCUSSION AND ANALYSIS

RESULTS OF OPERATIONS

         First American Health Concepts, Inc. ("FAHC" or the "Company") reported
a 9 percent  increase in operating  revenues,  with a growth from $7,172,000 for
1997 to  $7,809,000  for 1998.  Products  comprising  total  operating  revenues
include  non-insured  product revenues (ECPA Access) of $4,792,000,  insured and
self-funded  product  revenues (ECPA Select) of $2,064,000 and other  incidental
income of  $953,000.  The 9 percent  increase in  operating  income was achieved
despite a $38,000  decrease in  non-insured  product  revenues,  a reflection of
changing market demand for vision care  "discount" or savings  programs that the
Company has been  anticipating for several years.  Market research  continues to
show an  increasing  demand for  full-benefit,  managed  vision  care  programs,
especially among smaller businesses,  and the Company's growth in managed vision
care sales supports this trend.  Although the Company's  insured and self-funded
products  (ECPA  Select)  still  represent  a smaller  portion of the  Company's
business,  they are the  fastest  growing  business  segment.  The  Company  has
steadily  added to its capacity to support the delivery of managed  vision care,
and is well  positioned  for continued  growth.  Since the  introduction  of its
managed vision care programs in 1993, the Company has become an industry-leading
provider of managed vision care. The Company  anticipates that revenues from its
managed vision care programs  (insured and self-funded)  will continue to be the
source of growth in the future.  The  Company  does not  experience  significant
seasonal  fluctuations.  While the  non-insured  product  membership  is renewed
annually,  most fees are remitted and recognized

                                       7
<PAGE>

as revenue monthly.  The insured product and self-funded products are calculated
and billed monthly and recognized accordingly.

         Inflation  is not  expected  to have a material  effect on  revenues or
profits.

         Total operating expenses  increased 7 percent,  from $6,860,000 in 1997
to  $7,366,000  in  1998.  However,  total  operating  expenses  decreased  as a
percentage  of total  operating  revenue from 96% in 1997 to 94% in 1998.  While
increases in operating  expenses in recent years have reflected an investment in
the  infrastructure  necessary  to support  managed  vision  care,  this  year's
increase is in line with the increase in operating  revenues and indicates  that
much of the infrastructure investment is complete.

         Sales and  marketing  expenses  were  $2,005,000  in 1997  compared  to
$1,843,000  in 1998.  This 8 percent  decrease  was the result of a more focused
sales and marketing  strategy as well as the productivity  enhancements from the
standardization of processes and program offerings. Although sales and marketing
expenses  were down this past  year,  the  Company  added  sales  staff and will
continue  to add sales  staff as it grows  through a more  focused  distribution
strategy.

         Direct  membership  expenses  decreased 3 percent,  from $2,841,000 for
1997  compared to  $2,756,000  for 1998,  with the  completion  of a  multi-year
investment in an advanced vision care information  system.  This  comprehensive,
multi-year   transition   has   facilitated   paperless,    automated   benefits
administration and has been a significant  investment in the Company's future as
a leading  managed  vision care  provider.  Among the many  benefits of this new
system,  lower  membership  unit  costs  this past year  reflect  the  result of
bringing the claims  processing  function in-house for the first full year. With
the HSD managed vision care information  system in place, the costs of providing
members with  membership  materials,  maintaining a national  service center and
administering  claims  processing  are  expected  to  increase  more slowly than
increases in operating revenues in the future.

         General and administrative expenses were $1,647,000 in 1997 compared to
$2,189,000 in 1998.  Recent growth required a renovation and expansion of office
space this past year.  The 33 percent  increase  in general  and  administrative
expenses were the result of these one-time costs as well as some  administrative
costs of ECPA of California,  FAHC's California subsidiary, that has applied for
licensure as an HMO in California.

         Depreciation  increased  from $306,000 for 1997 to $519,000 for 1998. A
significant  portion of this  increase  was due to the HSD  managed  vision care
information system being in operation for its first full year.

         Interest  income was $194,000 in 1997 compared to $163,000 in 1998. The
decrease in interest  income was due to lower average  invested  balances during
the year ended July 31, 1998. The Company used internal funds to finance capital
expenditures and information systems development.

LIQUIDITY AND CAPITAL RESOURCES

         Working  capital was  $2,608,000  and the current ratio was 2.2 to 1 at
July 31, 1998. Cash and cash  equivalents and marketable  investment  securities
totaled $2,345,000.

         The Company's  cash and cash  equivalents  increased  $795,000 from the
1997 balance to $1,343,000 at July 31, 1998. The Company's  principal  source of
funds for the year ended July 31, 1998 was cash flow from investing activities.

         Management  anticipates  moderate  expansion  in 1999  through  capital
additions and  infrastructure  expenditures to accommodate  growth as it occurs.
The Company believes its ongoing cash flow will support all anticipated  capital
expenditures and operating expenses.

                                       8
<PAGE>
YEAR 2000 ISSUE

         The Year 2000 issue is the result of computer  programs  being  written
using two digits  (rather  than four) to define the  applicable  year.  Computer
programs that have time-sensitive  software may not recognize dates beginning in
the year 2000, which could result in miscalculations or system failures.

         The Company formed a Year 2000 Task Force over two years ago to perform
a comprehensive  review of its core business  applications  (i.e.  those systems
that  the  Company  is  dependent   upon  for  the  conduct  of  daily  business
operations).  The review was performed in conjunction  with planning  efforts to
enhance the  Company's  existing  infrastructure  and to support  the  Company's
addition of  full-benefit  insured and  self-funded  group vision care products.
From this effort, a managed vision care software system was purchased to support
the new products and to replace the software system utilized for the vision care
savings  product.  In addition,  other  information  systems were identified for
upgrade.  In no case was a system  replaced or purchased  solely because of Year
2000  issues.  Thus,  the Company  does not believe the costs of these  software
replacements are specifically Year 2000 related.

         The Company is currently waiting for improvements, related to Year 2000
issues,  from its software vendors.  These improvements are scheduled to arrive,
be tested and  implemented by the first half of 1999. The Company  believes that
it will  not  incur  additional  material  costs  in the  implementation  of the
improvements.  All personal  computers and related  equipment  have already been
reviewed and upgraded (if necessary) for any imbedded software that was not Year
2000 capable.

         The Year 2000 Task Force also assessed additional Year 2000 issues such
as  non-information   technology   systems  (i.e.   telephone   systems).   Some
improvements  and/or upgrades were identified as a result of the review. As with
the information  technology  systems,  the review was made in conjunction with a
formal  planning  process  to  enhance  infrastructure.  All  upgrades  will  be
completed  by November  1998.  The Task Force is also  reviewing  the  Company's
relationships  with vendors,  financial  institutions and other third parties to
identify possible Year 2000 issues.

         The Company is aware that it could be  adversely  affected by Year 2000
issues in that  purchasing  patterns of customers or potential  customers may be
affected by Year 2000  issues as  companies  expense  significant  resources  to
correct their current systems for Year 2000 compliance.  These  expenditures may
result in reduced funds available to purchase  services such as those offered by
the  Company,  which  could have an adverse  effect on the  Company's  business,
operating results and financial  condition.  Given the information  available at
this  time,  management  believes  that this  issue  should  not have a material
adverse  effect on the  Company's  liquidity,  its results of  operations or its
customers.

         The  Company  has not at this  time  established  a  formal  Year  2000
contingency  plan but will consider and, if necessary,  address doing so as part
of its Year 2000 Task Force  activities.  The Company does maintain  contingency
plans designed to address other  potential  business  interruptions  that may be
usable in this situation.

CONTRACTUAL ARRANGEMENTS

         The Company's insured line of business is underwritten by Security Life
Insurance  Company of  America  (SLICA)  and The MEGA Life and Health  Insurance
Company  (MEGA).  According to the management  agreement with SLICA (dated April
15, 1992),  SLICA is  responsible to "process,  investigate,  settle and pay all
claims  arising,"  including  claims  underwritten  by the MEGA Life and  Health
Insurance  Company.  The Company  assumes  both  premium and risk of loss on the
policies  under the terms of a  Reinsurance  Agreement  between  First  American
Reinsurance  Company (FARC) and SLICA (dated January 1, 1998).  The risk of loss
is based upon the schedule of benefits attached to each policy.  The revenue and
expenses  associated  with this  agreement were not material for the year ending
July 31, 1998, and were therefore not shown as a separate  income  statement and
balance sheet component.

                                       9
<PAGE>
LICENSURE ISSUES

         The Company markets and  administers  insured vision care under its own
licenses or the  license of its  insurance  carrier in each state where  insured
vision  care is  provided.  To meet  legal and  regulatory  requirements,  a new
subsidiary,  First  American  Administrators,  Inc. (FAA) was created to provide
these  services.  During  this past  year,  both FAHC and FAA  obtained  various
third-party  administrator licenses in markets where they do business.  However,
due  to  rigorous   regulatory   requirements  in  some  markets  and  competing
operational  priorities,  this process was not  completed in all markets.  It is
anticipated that this licensing process will be complete in 1999.

         The primary licensing  activity  involving FAHC's  subsidiary,  ECPA of
California,  resulted  in  the  filing  of an  application  for  licensure  as a
Specialized  Knox-Keene  Health  Care  Services  Organization  in the  State  of
California.  Upon review and  approval  of this  application  by the  California
Department of Corporations, ECPA of California, together with FAHC, will provide
a complete complement of vision care services in the State of California.

RECENT ACCOUNTING PRONOUNCEMENTS

         In  February  1997,  the  FASB  issued  SFAS  No.  129,  DISCLOSURE  OF
INFORMATION  ABOUT  CAPITAL  STRUCTURE,   to  consolidate   existing  disclosure
requirements.  This new standard  contains no change in disclosure  requirements
for the Company. It was effective for the Company for the quarter ending January
31, 1998.

         In June 1997,  the FASB issued SFAS No.  130,  REPORTING  COMPREHENSIVE
INCOME, to establish standards for reporting and display of comprehensive income
(all changes in equity during a period except those  resulting from  investments
by and distributions to owners) and its components in financial statements. This
new standard, which will be effective for the Company for the fiscal year ending
July 31, 1999, is not currently  anticipated to have a significant impact on the
Company's  financial  statements  based on the current  financial  structure and
operations of the Company.

         In June 1997, the FASB issued SFAS No. 131,  DISCLOSURES ABOUT SEGMENTS
OF AN ENTERPRISE AND RELATED  INFORMATION,  to establish standards for reporting
information about operating  segments in annual financial  statements,  selected
information   about  operating   segments  in  interim   financial  reports  and
disclosures  about products and services,  geographic areas and major customers.
This new  standard,  which will be effective for the Company for the fiscal year
ending July 31, 1999, will require the Company to report  financial  information
on the basis that is used  internally for  evaluating  segment  performance  and
deciding how to allocate resources to segments,  which is currently  anticipated
to result in more detailed  information in the notes to the Company's  financial
statements than is currently required and provided.

         In February 1998, the FASB issued SFAS No. 132, EMPLOYERS'  DISCLOSURES
ABOUT PENSIONS AND OTHER  POSTRETIREMENT  BENEFITS,  which revises  requirements
concerning employers' disclosures about pension and other postretirement benefit
plans.  It does not change the  measurement or recognition of those plans.  This
new standard, which will be effective for the Company for the fiscal year ending
July 31, 1999, is not currently  anticipated to have a significant impact of the
Company's  financial  statements  based on the current  financial  structure and
operations of the Company.

         In April  1998,  the AICPA  Accounting  Standards  Executive  Committee
issued SOP 98-5, REPORTING THE COSTS OF START-UP ACTIVITIES, which requires that
costs incurred  during start-up  activities,  including  organization  costs, be
expensed as incurred.  Application  of the SOP should be as of the  beginning of
the fiscal year in which the SOP is first adopted,  and it should be reported as
a cumulative  effect of a change in  accounting  principle.  This new  standard,

                                       10
<PAGE>
which will be effective for the Company for the fiscal year ending July 31, 2000
is being evaluated by management to determine its applicability,  and effect, on
future periods.

         In June 1998,  the FASB issued SFAS No. 133,  ACCOUNTING FOR DERIVATIVE
INSTRUMENTS AND HEDGING ACTIVITIES,  which establishes  accounting and reporting
standards for  derivative  instruments  and for and for hedging  activities.  It
requires  that  an  entity   recognize  all  derivatives  as  either  assets  or
liabilities in the balance sheet and that these  instruments be measured at fair
value. This new standard, which will be effective for the Company for the fiscal
year ending July 31, 2000,  is not currently  anticipated  to have a significant
impact on the  Company's  financial  statements  based on the current  financial
structure and operations of the Company.

         There are certain matters  affecting  accounting and disclosure,  which
have been  pronounced by  authoritative  accounting  bodies other than the FASB.
Management  has evaluated  and  implemented  those  currently  required,  and is
evaluating the applicability and impact of those pronouncements that are not yet
effective.

ITEM 7.  FINANCIAL STATEMENTS

         The Company's  financial  statements  and notes thereto are included in
this report beginning at page 15.

ITEM  8.  CHANGES  IN AND  DISAGREEMENTS  WITH  ACCOUNTANTS  ON  ACCOUNTING  AND
FINANCIAL DISCLOSURE

         None.

                                       11
<PAGE>
PART III

ITEM 9. DIRECTORS, EXECUTIVE OFFICERS, PROMOTERS AND CONTROL PERSONS; COMPLIANCE
WITH SECTION 16 (A) OF THE EXCHANGE ACT

         The information called for by this Item, with respect to directors, and
with respect to officers regarding compliance with Section 16(a) is incorporated
by reference from the "Notice of Meeting and Proxy  Statement" filed herewith as
Exhibit 28.
                                             Current Title and Positions
Executive Officer  Age at 7/31/98            Held During the Last Five Years
- -----------------  --------------            -------------------------------
John A. Raycraft   51      Chief  Executive  Officer  since May 1993;  President
                           since 1992;  Executive  Vice  President  from 1991 to
                           1992.

Laura J. Arnold    37      Vice  President  of Provider  Relations  since August
                           1994;  Manager since August 1993;  Director of Vision
                           and Hearing Plan Services/Southwestern  Benefit Plans
                           and Network  Development  with AVESIS,  Inc. prior to
                           joining the Company.

Deborah L. Brady   41      Vice  President  of  Administration  since June 1997;
                           Membership  Accounting  Manager  for FHP Health  Care
                           from  1996 to  1997,  Operations  Manager  for  CIGNA
                           HealthCare  from 1995 to 1996,  Director & Manager of
                           Enrollment  Processing for PCS Health  Systems,  Inc.
                           from 1993 to 1995.

James D. Hyman     53      Vice  President of  Marketing  and Sales since August
                           1998;  a Principal & Vice  President  of Managed Care
                           for  Physicians  Eyecare  Network,  Inc. from 1993 to
                           1996,  Vice  President of Marketing for Davis Vision,
                           Inc. from 1987 to 1993.

Bruce T. Davidson  66      Vice President of Corporate  Development since August
                           1998;  Vice  President of  Marketing  and Sales since
                           November  1995;  an  independent  marketing and sales
                           consultant prior to joining the Company.

Carolyn Hall       58      Secretary and Treasurer since 1988; Secretary since
                           1987.

Margaret Eardley   29      Vice President of Finance and Chief Financial Officer
                           since  October  1998;  Vice  President of Finance for
                           Cedar Hill Assurance  Company from 1997 to 1998, Vice
                           President & Treasurer,  Assistant  Vice  President of
                           Finance and  Finance  Manager  for  Republic  Western
                           Insurance Company from 1991 to 1997.

Craig Santilli     50      Vice President of Information Systems since September
                           1995;   Director,    Applications   Development   for
                           Samaritan   Health  System  from  1993  to  1995  and
                           Director,   Information   Management   for   Hartford
                           Insurance Group from 1983 to 1993.

                                       12
<PAGE>
ITEM 10. EXECUTIVE COMPENSATION

         The  information  called for by this Item is  incorporated by reference
from the "Notice of Meeting and Proxy Statement" filed herewith as Exhibit 28.

ITEM 11. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT

         The  information  called for by this Item is  incorporated by reference
from the "Notice of Meeting and Proxy Statement" filed herewith as Exhibit 28.

ITEM 12. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS

         The Company has an outstanding  note  receivable due from the President
and Chief Executive  Officer.  The note is secured by an insurance policy on the
life of the officer.  The terms of the note require annual installments  through
August 1, 1999. The balance of the note on July 31, 1998 was $45,525.

         Additional  information  called  for by this  Item is  incorporated  by
reference  from the "Notice of Meeting and Proxy  Statement"  filed  herewith as
Exhibit 28.

ITEM 13. EXHIBITS AND REPORTS ON FORM 8-K

(A) Exhibits

Exhibit Number                 Description             Method of Filing
- --------------                 -----------             ----------------
3-A          Articles of Incorporation of the    Incorporated by reference to
             Company as amended                  Exhibit 3-A of 1990 10-K.

3-B          Bylaws of the Company               Incorporated by reference to
                                                 Exhibit 3-B of 1992 10-K.

4-A          Specimen Stock Certificate          Incorporated by reference to
                                                 Exhibit 4-A of S-18 33-00118-LA

27           Financial Data Schedule             Exhibit Filed herewith

28           Notice of Meeting and Proxy         Incorporated by reference to
             Statement                           the Company's 1998 Definitive
                                                 Notice and Proxy Statement.
(B) Reports on Form 8-K

No  reports on Form 8-K have been  filed  during the last  quarter of the period
covered by this report.

                                       13
<PAGE>
                                   SIGNATURES

In accordance  with Section 13 or 15 (d) of the Exchange Act, the registrant has
caused this report to be signed on its behalf by the undersigned, thereunto duly
authorized.

                                   FIRST AMERICAN HEALTH CONCEPTS, Inc.
                                              (Registrant)

Date:  October 23, 1998
                                        By /s/ John A. Raycraft
                                           ----------------------------------
                                        John A. Raycraft
                                        President and Chief Executive Officer

In  accordance  with the Exchange  Act, this report has been signed below by the
following  persons on behalf of the  registrant and in the capacities and on the
dates indicated.

       Signature                           Title                        Date
       ---------                           -----                        ----

/s/ John A. Raycraft             President and                        10/23/98
- -----------------------          Chief Executive Officer
(John A. Raycraft)

/s/ Brian Kay                    Controller                           10/23/98
- -----------------------
(Brian Kay

/s/ John R. Behrmann             Chairman of the Board                10/23/98
- -----------------------
(John R. Behrmann)

/s/ Robert J. Delsol             Director                             10/23/98
- -----------------------
Robert J. Delsol

/s/ John W. Heidt                Vice Chairman of the Board           10/23/98
- -----------------------
(John W. Heidt)

/s/ Thomas B. Morgan             Director                             10/23/98
- -----------------------
(Thomas B. Morgan)

/s/ James J. Meenaghan           Director                             10/23/98
- -----------------------
(James J. Meenaghan)

/s/ Robert M. Topol              Director                             10/23/98
- -----------------------
(Robert M. Topol)

                                       14
<PAGE>














                      FIRST AMERICAN HEALTH CONCEPTS, INC.
                                AND SUBSIDIARIES

                        Consolidated Financial Statements

                                  July 31, 1998

                   (With Independent Auditors' Report Thereon)

<PAGE>





                          INDEPENDENT AUDITORS' REPORT



The Board of Directors and Shareholders
First American Health Concepts, Inc.:


We have audited the  accompanying  consolidated  balance sheet of First American
Health  Concepts,  Inc. and  subsidiaries  as of July 31, 1998,  and the related
consolidated statements of income, shareholders' equity, and cash flows for each
of the years in the  two-year  period ended July 31,  1998.  These  consolidated
financial  statements are the  responsibility of the Company's  management.  Our
responsibility  is  to  express  an  opinion  on  these  consolidated  financial
statements based on our audits.

We  conducted  our  audits  in  accordance  with  generally   accepted  auditing
standards.  Those standards require that we plan and perform the audit to obtain
reasonable assurance about whether the financial statements are free of material
misstatement.  An audit includes examining, on a test basis, evidence supporting
the amounts and disclosures in the financial statements.  An audit also includes
assessing the  accounting  principles  used and  significant  estimates  made by
management,  as well as evaluating the overall financial statement presentation.
We believe that our audits provide a reasonable basis for our opinion.

In our opinion, the consolidated  financial statements referred to above present
fairly,  in all material  respects,  the  financial  position of First  American
Health  Concepts,  Inc. and  subsidiaries as of July 31, 1998 and the results of
their  operations  and their  cash  flows for each of the years in the  two-year
period ended July 31, 1998 in  conformity  with  generally  accepted  accounting
principles.





KPMG Peat Marwick LLP




Phoenix, Arizona
October 9, 1998
<PAGE>
              FIRST AMERICAN HEALTH CONCEPTS, INC. AND SUBSIDIARIES

                           Consolidated Balance Sheet

                                  July 31, 1998


                                     ASSETS

Current assets:
    Cash and cash equivalents                                     $ 1,342,759
    Marketable investment securities (note 2)                       1,002,158
    Member fees receivable, net of allowance of $37,870             1,386,446
    Note receivable-- officer (note 3)                                 45,525
    Deferred costs                                                    246,318
    Prepaid expenses                                                  126,270
    Income taxes receivable                                           249,902
    Other current assets                                              443,848
                                                                  -----------
           Total current assets                                     4,843,226
                                                                  -----------
Property and equipment:
    Office furniture and fixtures                                     316,553
    Computers and office equipment                                  3,245,154
    Leasehold improvements                                            197,750
                                                                  -----------
                                                                    3,759,457
    Less accumulated depreciation and amortization                 (1,759,087)
                                                                  -----------
           Net property and equipment                               2,000,370
                                                                  -----------
Deferred costs                                                        692,814
                                                                  -----------

           Total assets                                           $ 7,536,410
                                                                  ===========
                      LIABILITIES AND SHAREHOLDERS' EQUITY

Current liabilities:
    Accounts payable                                              $   207,659
    Capital lease obligation, current (note 4)                          9,631
    Bank loan, current (note 7)                                        84,400
    Accrued expenses                                                  154,953
    Deferred tax liability                                            504,155
    Deferred revenue                                                1,274,427
                                                                  -----------
           Total current liabilities                                2,235,225

Bank loan, long-term (note 7)                                          21,100
                                                                  -----------
           Total liabilities                                        2,256,325
                                                                  -----------
Shareholders' equity (notes 6 and 7):
    Common stock, no par value; authorized, 8,000,000
     shares; issued 3,032,838 shares                                  681,546
    Additional paid-in capital                                      2,554,348
    Retained earnings                                               3,623,820
    Unearned ESOP shares (note 7)                                     (95,945)
    Net unrealized gain on marketable investment
     securities (note 2)                                                2,048
                                                                  -----------
                                                                    6,765,817
    Treasury stock, at cost, 468,102 shares                        (1,485,732)
                                                                  -----------
           Total shareholders' equity                               5,280,085
                                                                  -----------
Commitments and contingencies (notes 4, 7, 9 and 10)

           Total liabilities and shareholders' equity             $ 7,536,410
                                                                  ===========

See accompanying notes to consolidated financial statements.
<PAGE>
              FIRST AMERICAN HEALTH CONCEPTS, INC. AND SUBSIDIARIES

                        Consolidated Statements of Income

                       Years ended July 31, 1998 and 1997


                                                       1998           1997
                                                   -----------    -----------

Operating revenues                                 $ 7,809,122      7,171,909

Operating expenses:
    Sales and marketing expenses                     1,842,518      2,005,360
    Direct membership expenses                       2,755,751      2,840,645
    General and administrative expenses              2,188,694      1,646,825
    Depreciation                                       519,319        305,602
    ESOP charges (note 7)                               59,951         61,388
                                                   -----------    -----------
           Total operating expenses                  7,366,233      6,859,820
                                                   -----------    -----------

           Operating income                            442,889        312,089
                                                   -----------    -----------
Non-operating income (expense):
    Interest income                                    163,164        194,157
    Interest expense                                   (16,286)       (25,885)
                                                   -----------    -----------
           Total non-operating income                  146,878        168,272
                                                   -----------    -----------

           Income before income taxes                  589,767        480,361

Income taxes (note 8)                                  239,049        184,000
                                                   -----------    -----------

           Net income                              $   350,718        296,361
                                                   ===========    ===========

Net income per share - basic                       $      0.14           0.12
                                                   ===========    ===========

Net income per share - diluted                     $      0.14           0.11
                                                   ===========    ===========
Weighted average common and equivalent
 shares outstanding - basic                          2,559,750      2,513,492
                                                   ===========    ===========
Weighted average common and equivalent
 shares outstanding - diluted                        2,559,750      2,577,868
                                                   ===========    ===========

See accompanying notes to consolidated financial statements.
<PAGE>
              FIRST AMERICAN HEALTH CONCEPTS, INC. AND SUBSIDIARIES

                 Consolidated Statements of Shareholders' Equity

                             July 31, 1998 and 1997


                               Outstanding               Additional
                                 Common      Common       Paid-in     Retained
                                 Shares       Stock       Capital     Earnings
                                 ------       -----       -------     --------

Balances at July 31, 1996       2,612,002    $630,306    2,560,544    2,976,741

Stock options exercised            17,734      24,990           --           --
Net unrealized gain (loss)
    on marketable invest-
    ment securities                    --          --           --           --
Income tax benefit arising
    from employee stock
    option plan                        --          --       14,931           --
Purchase of treasury stock        (85,000)         --           --           --
Cost of ESOP shares
    released                           --          --      (23,252)          --
Net income                             --          --           --      296,361
                               ----------    --------   ----------    ---------

Balances at July 31, 1997       2,544,736     655,296    2,552,223    3,273,102

Stock options exercised            20,000      26,250           --           --
Net unrealized gain (loss)
    on marketable invest-
    ment securities                    --          --           --           --
Income tax benefit arising
    from employee stock
    option plan                        --          --       21,393           --
Purchase of treasury stock             --          --           --           --
Cost of ESOP shares
    released                           --          --      (19,268)          --
Net income                             --          --           --      350,718
                               ----------    --------   ----------    ---------

Balances at July 31, 1998       2,564,736    $681,546    2,554,348    3,623,820
                               ==========    ========   ==========    =========
<PAGE>

                                          Net Unrealized
                                          Gain (Loss) on
                               Unearned     Marketable                 Total
                                 ESOP       Investment  Treasury   Shareholders'
                                Shares      Securities   Stock         Equity
                                ------      ----------   -----         ------

Balances at July 31, 1996      (259,804)     (1,613)   (1,141,442)    4,764,732

Stock options exercised              --          --            --        24,990
Net unrealized gain (loss)
    on marketable invest-
    ment securities                  --       6,536            --         6,536
Income tax benefit arising
    from employee stock
    option plan                      --          --            --        14,931
Purchase of treasury stock           --          --      (344,290)     (344,290)
Cost of ESOP shares
    released                     84,640          --            --        61,388
Net income                           --          --            --       296,361
                               --------      ------    ----------    ----------

Balances at July 31, 1997      (175,164)      4,923    (1,485,732)    4,824,648

Stock options exercised              --          --            --        26,250
Net unrealized gain (loss)
    on marketable invest-
    ment securities                  --      (2,875)           --        (2,875)
Income tax benefit arising
    from employee stock
    option plan                      --          --            --        21,393
Purchase of treasury stock           --          --            --            --
Cost of ESOP shares
    released                     79,219          --            --        59,951
Net income                           --          --            --       350,718
                               --------      ------    ----------    ----------

Balances at July 31, 1998       (95,945)      2,048    (1,485,732)    5,280,085
                               ========      ======    ==========    ==========

See accompanying notes to consolidated financial statements.
<PAGE>
              FIRST AMERICAN HEALTH CONCEPTS, INC. AND SUBSIDIARIES

                      Consolidated Statements of Cash Flows

                       Years ended July 31, 1998 and 1997

                                                           1998         1997
                                                           ----         ----
Cash flows from operating activities:
    Net income                                          $  350,718      296,361
    Adjustments to reconcile net income to net
     cash provided by (used in) operating activities:
      Depreciation                                         519,319      305,602
      Amortization of deferred system costs                     --       49,321
      Income tax benefit arising from stock option plan     21,393       14,931
      ESOP shares committed to be released                  59,951       61,388
      Provision for losses on accounts receivable           37,870           --
      Increase in deferred taxes                           406,155       78,000
      Changes in assets and liabilities:
        Increase in member fees receivable                (298,589)    (476,215)
        Increase in deferred costs                        (707,864)      (7,296)
        Increase in prepaid expenses and other
          current assets                                  (277,941)     (97,173)
        (Increase) in income taxes receivable             (127,061)     (90,034)
        Increase (decrease) in accounts payable             23,184      (31,875)
        Decrease in accrued expenses                       (37,243)     (60,145)
        Increase (decrease) in deferred revenue           (111,327)     222,806
                                                        ----------   ----------
           Net cash provided by (used in)
            operating activities                          (141,435)     265,671
                                                        ----------   ----------
Cash flows from investing activities:
    Purchases of property and equipment                   (430,394)  (1,078,816)
    Purchases of marketable investment securities         (380,709)  (1,245,459)
    Redemptions/sales of marketable investment
     securities                                          1,809,112    1,411,345
    Decrease in note receivable-- officer                   16,999       16,220
                                                        ----------   ----------
           Net cash provided by (used in)
            investing activities                         1,015,008     (896,710)
                                                        ----------   ----------
Cash flows from financing activities:
    Repayments of bank loan                                (84,400)     (84,400)
    Repayments of capital lease obligation                 (20,350)     (17,141)
    Proceeds from exercised stock options                   26,250       24,990
    Purchases of treasury stock                                 --     (344,290)
                                                        ----------   ----------
           Net cash used in financing activities           (78,500)    (420,841)
                                                        ----------   ----------
           Net increase (decrease) in cash
            and cash equivalents                           795,073   (1,051,880)

Cash and cash equivalents, beginning of year               547,686    1,599,566
                                                        ----------   ----------

Cash and cash equivalents, end of year                  $1,342,759      547,686
                                                        ==========   ==========
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:

Cash paid during the year for income taxes              $       --      180,949
                                                        ==========   ==========

Cash paid during the year for interest                  $   13,418       25,885
                                                        ==========   ==========
SUPPLEMENTAL DISCLOSURES OF NON-CASH
INVESTING ACTIVITIES:

Unrealized gain (loss) on marketable
  investment securities                                 $   (2,875)       6,536
                                                        ==========   ==========

See accompanying notes to consolidated financial statements.
<PAGE>
              FIRST AMERICAN HEALTH CONCEPTS, INC. AND SUBSIDIARIES

                   Notes to Consolidated Financial Statements

                             July 31, 1998 and 1997


(1)    SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

       BUSINESS DESCRIPTION AND REVENUE RECOGNITION

       First  American  Health  Concepts,  Inc.  (FAHC or the Company)  receives
       membership  fees  through  its  various  Eye Care Plan of America  (ECPA)
       programs.  ECPA Non-Insured  membership generally is renewed annually and
       fees are remitted to the Company monthly by sponsors, based on the number
       of members  represented by the sponsor.  Revenues are recognized  monthly
       based  on the  aggregate  number  of  members  reported  to the  Company.
       Membership  fees may also be  remitted  on an annual  basis and,  in such
       cases,  are  amortized  ratably  to income  over a  twelve-month  period.
       Premiums and fees related to ECPA Insured and ECPA  Self-Funded  Programs
       are calculated and billed on a monthly basis and recognized  accordingly.
       The premium for these  policies  is  remitted  directly to the  insurance
       carrier.  For policies  incepting prior to January 1, 1998, the insurance
       carrier  remits  fees to the  Company  on a monthly  basis.  The  Company
       created a captive reinsurance company, First American Reinsurance Company
       (FARC) in January 1998.  Therefore,  for policies incepting after January
       1,  1998,  the  insurance  carrier  remits a quota  share  portion of the
       premium to the Company on a monthly basis.

       PRINCIPLES OF CONSOLIDATION

       The consolidated financial statements include the financial statements of
       the  Company and its three  wholly-owned  subsidiaries.  All  significant
       intercompany   balances  and   transactions   have  been   eliminated  in
       consolidation.

       CASH AND CASH EQUIVALENTS

       The Company considers all highly liquid financial  instruments  purchased
       with an original maturity of three months or less to be cash equivalents.

       DEVELOPMENT COSTS

       The  Company  expenses  its  costs of  developing  the eye care  provider
       network and sponsor network as they are incurred.

       MARKETABLE INVESTMENT SECURITIES

       Marketable  investment  securities  at  July  31,  1998  consist  of U.S.
       Treasury  securities.  Under the  provisions  of  Statement  of Financial
       Accounting  Standards (SFAS) No. 115,  ACCOUNTING FOR CERTAIN INVESTMENTS
       IN DEBT AND EQUITY SECURITIES, the Company classifies its debt securities
       as  available  for sale and such  securities  are recorded at fair value.
       Unrealized holding gains and losses on available-for-sale securities, net
       of related tax effects,  are excluded from earnings and are reported as a
       separate component of shareholders' equity until realized. Realized gains
       and losses on  securities  are included in earnings and are derived using
       the specific identification method for determining the cost of securities
       sold.

                                       1
<PAGE>
              FIRST AMERICAN HEALTH CONCEPTS, INC. AND SUBSIDIARIES

              Notes to Consolidated Financial Statements, Continued

       DEFERRED COSTS

       The  Company   defers  the  direct  costs  of   initiating   vision  plan
       memberships.  Such costs, which include  commissions,  printing and other
       materials, are amortized over a twelve-month period, which corresponds to
       the  period   utilized  for  measurement  of  membership   fees.   Direct
       advertising costs are expensed as incurred.

       Non-current  deferred  costs relate  primarily to direct and  incremental
       costs associated with activities in key geographical locations, and which
       are capitalized until the commencement of operations,  at which time they
       are charged to operations.

       PROPERTY AND EQUIPMENT

       Property and  equipment  are recorded at cost.  Depreciation  is provided
       using the  straight-line  method over estimated  useful lives of three to
       five years. Equipment under capital leases and leasehold improvements are
       amortized  using the  straight-line  method over the shorter of the lease
       term or the estimated  useful life of the asset.  Costs of the integrated
       managed care  information  system are amortized  using the  straight-line
       method over a seven-year period.

       NET INCOME PER SHARE

       The Company adopted  Statement of Accounting  Standards No. 128 "Earnings
       per Share" (SFAS 128) during 1998. The Company's net income per share for
       the prior period was not materially  effected by adoption of SFAS 128. In
       accordance  with SFAS 128,  basic net  income  per share is  computed  by
       dividing  net  income,   after   deducting   preferred   stock  dividends
       requirements (if any), by the weighted average number of shares of common
       stock outstanding.

       Diluted net income per share  reflects  the maximum  dilution  that would
       result after giving effect to dilutive  stock options and warrants and to
       the assumed conversion of all dilutive convertible securities and stock.

       Weighted  average  outstanding  shares do not include  shares held by the
       Employee Stock  Ownership Plan at July 31, 1998 and 1997.  Shares held by
       the  ESOP  are not  considered  outstanding  for  net  income  per  share
       calculations until the shares are released to the employees accounts.

       STOCK OPTION PLAN

       The Company  accounts  for its stock option plan in  accordance  with the
       provisions  of SFAS No. 123,  ACCOUNTING  FOR  STOCK-BASED  COMPENSATION,
       which  permits  entities to recognize as expense over the vesting  period
       the  fair  value  of  all  stock-based  awards  on  the  date  of  grant.
       Alternatively,  SFAS No. 123 also allows entities to apply the provisions
       of APB Opinion No. 25,  ACCOUNTING  FOR STOCK  ISSUED TO  EMPLOYEES,  and
       related  operations  and  provide  pro  forma  net  income  and pro forma
       earnings per share disclosures for employee stock option grants as if the
       fair-value-based  method  defined in SFAS No. 123 had been  applied.  The
       Company  has  elected to apply the  provisions  of APB Opinion No. 25 and
       provide the pro forma disclosure provisions of SFAS No. 123.

                                       2
<PAGE>
              FIRST AMERICAN HEALTH CONCEPTS, INC. AND SUBSIDIARIES

              Notes to Consolidated Financial Statements, Continued

       INCOME TAXES

       Deferred tax assets and  liabilities  are  recognized  for the  estimated
       future tax consequences attributable to differences between the financial
       statement  carrying  amounts of existing assets and liabilities and their
       respective tax bases.  Deferred tax assets and  liabilities  are measured
       using  enacted tax rates in effect for the year in which those  temporary
       differences are expected to be recovered or settled.

       IMPAIRMENT OF LONG-LIVED ASSETS

       SFAS No. 121,  ACCOUNTING FOR THE IMPAIRMENT OF LONG-LIVED ASSETS AND FOR
       LONG-LIVED  ASSETS TO BE DISPOSED OF, requires that long-lived assets and
       certain  identifiable  intangibles  be reviewed for  impairment  whenever
       events or changes in  circumstances  indicate that the carrying amount of
       an asset may not be recoverable.  Recoverability of assets to be held and
       used is measured by a comparison  of the  carrying  amount of an asset to
       future net cash flows  expected  to be  generated  by the asset.  If such
       assets are considered to be impaired,  the impairment to be recognized is
       measured by the amount by which the carrying amount of the assets exceeds
       the fair value of the assets.  Assets to be  disposed of are  reported at
       the lower of the carrying amount or fair value less costs to sell.

       FAIR VALUE OF FINANCIAL INSTRUMENTS

       Fair value  estimates  of  financial  instruments  are made at a specific
       point  in  time  and  are  based  on  relevant  market   information  and
       information about the financial instrument; they are subjective in nature
       and involve uncertainties and matters of judgment and, therefore,  cannot
       be determined with precision.  Changes in assumptions could significantly
       affect these  estimates  and,  since the fair values are  estimated as of
       July 31,  1998,  the  amounts  that will  actually be realized or paid at
       settlement  or  maturity  of  the  instruments   could  be  significantly
       different.   The  Company   does  not  trade  in   derivative   financial
       instruments.

       Management  believes  that the  recorded  amount of  current  assets  and
       current liabilities  approximate fair value because of the short maturity
       of these instruments. The recorded balance of long-term debt approximates
       fair  value,  as the  terms of the debt are  similar  to rates  currently
       offered to the Company for similar debt instruments.

       USE OF ESTIMATES

       Management has made a number of estimates and assumptions relating to the
       reporting of assets and liabilities,  disclosure of contingent assets and
       liabilities,  and the reporting of revenues and expenses to prepare these
       financial  statements in conformity  with generally  accepted  accounting
       principles. Actual results could differ from those estimates.

       RECLASSIFICATION

       Certain accounts related to prior years have been reclassified to conform
       to current year presentation.

                                       3
<PAGE>
              FIRST AMERICAN HEALTH CONCEPTS, INC. AND SUBSIDIARIES

              Notes to Consolidated Financial Statements, Continued

(2)    MARKETABLE INVESTMENT SECURITIES

       At July 31, 1998, the amortized cost, net of unrealized holding gains and
       the fair value of  available-for-sale  securities by major  security type
       were as  follows.  There were no  realized  gains or losses  included  in
       income in 1998.

                                                   NET UNREALIZED
                                                       HOLDING
                                       COST             GAINS         FAIR VALUE
                                    ----------       ----------       ----------

       Equity Securities            $   71,250             --             71,250
       U.S. Treasury Securities        928,860            2,048          930,908
                                    ----------       ----------       ----------

                                    $1,000,110            2,048        1,002,158
                                    ==========       ==========       ==========


       Although  there is a  concentration  of credit  risk  related to the U.S.
       Treasuries,  management  does not consider  these  investments to be high
       risk.

       All  marketable  investment  securities  are scheduled to mature prior to
       July 31, 1999.


(3)    NOTE RECEIVABLE - OFFICER

       The Company has an outstanding note receivable due from the President and
       Chief Executive  Officer.  The note is secured by an insurance  policy on
       the  life  of  the  officer.   The  terms  of  the  note  require  annual
       installments  through August 1, 1999. The balance of the note on July 31,
       1998 was $45,525.


(4)    LEASE OBLIGATIONS

       The  Company  leases  telephone  equipment  under  the terms of a capital
       lease. The terms provide for 60 monthly installments of $1,867, including
       principal and interest  through  January  1999. At July 31, 1998,  office
       equipment included $82,052 and accumulated  amortization included $73,847
       related to the leased equipment.

                                       4
<PAGE>
              FIRST AMERICAN HEALTH CONCEPTS, INC. AND SUBSIDIARIES

              Notes to Consolidated Financial Statements, Continued

       Following is a schedule by year of future minimum lease payments:

                           YEAR ENDING JULY 31,               1998

                   Future minimum lease payments           $  11,202
                   Less amount representing interest           1,571
                                                              ------

                   Principal balance                           9,631

                   Less current portion                       (9,631)
                                                              ------

                   Long-term portion                       $      --
                                                              ======


       The Company also operates from leased  premises under  operating  leases.
       Rental expense  related to these leases was $289,712 in 1998 and $240,499
       in 1997.

       Future minimum lease payments under noncancelable  operating leases as of
       July 31, 1998 are as follows:

                          YEARS ENDING JULY 31,

                                  1999              $   262,827
                                  2000                  299,216
                                  2001                  312,610
                                  2002                  320,984
                                  2003                   53,730
                                                     ----------

                                                    $ 1,249,367
                                                     ==========

 (5)   NET INCOME PER SHARE

       Options for 64,375  shares of common  stock were  included in diluted EPS
       for 1997.  Options  to  purchase  281,902  shares  of common  stock at an
       average  price of $4.19 were  outstanding  at July 31,  1998 but were not
       included in the computation of diluted EPS because the options'  exercise
       price was greater than the average market price of the common shares.

(6)    STOCK OPTIONS

       The Company stock option plan (the "Plan")  which covered all  employees,
       officers  and  directors  of the Company and provided for the granting of
       incentive and  non-qualified  stock options expired on December 31, 1997,
       however,  under the Plan, all outstanding options that were granted prior
       to the Plan expiration  continue in full force and effect until exercised
       or expired  under the  provisions of the Plan as if the Plan had remained
       in full force and effect. The Company is in the process of adopting a new
       Executives Incentive Plan which is subject to shareholder approval.

                                       5
<PAGE>
              FIRST AMERICAN HEALTH CONCEPTS, INC. AND SUBSIDIARIES

              Notes to Consolidated Financial Statements, Continued

       Options  were  granted at not less than fair market  value on the date of
       grant and  become  exercisable  based on  conditions  set by the Board of
       Directors.  Options  generally  expire if  unexercised  at the end of ten
       years for  incentive  stock  options and eleven  years for  non-qualified
       stock options.

       As  previously  discussed,  the  Company  applies  APB Opinion No. 25 and
       related  interpretations  in  accounting  for the Plan.  Accordingly,  no
       compensation cost has been recognized for the Plan.

       Had compensation costs for the Company's plan been determined  consistent
       with FASB  Statement No. 123, the Company's net income and net income per
       share would have been the same as those reported.

       At July 31, 1998,  no stock  options were  available for grant under this
       plan and 179,069  stock  options were  exercisable.  Activity  related to
       stock options is summarized, as follows:

<TABLE>
<CAPTION>
                                    INCENTIVE STOCK OPTIONS      NONQUALIFIED STOCK OPTIONS
                                   -------------------------     --------------------------
                                                   WEIGHTED                       WEIGHTED
                                                   AVERAGE                        AVERAGE
                                                    OPTION                         OPTION
                                    NUMBER         PRICE PER      NUMBER          PRICE PER
     DATE           ACTIVITY       OF SHARES         SHARE       OF SHARES          SHARE
- -------------      -----------     ----------      ---------     ---------        ---------

<S>                <C>             <C>             <C>           <C>              <C>
July 31, 1996      Outstanding       62,102        $  4.71        275,000         $  4.30
                   Granted               --            --              --              --
                   Exercised         (2,734)          1.71        (15,000)           1.35
                   Expired          (11,233)          5.52        (15,000)           6.06
                                   ----------      ---------     ---------        ---------

July 31, 1997      Outstanding       48,135           4.69        245,000            4.37
                   Granted               --            --          17,500            3.31
                   Exercised             --            --         (20,000)           1.31
                   Expired           (8,733)          5.60             --              --
                                   ----------      ---------     ---------        ---------

July 31, 1998      Outstanding       39,402        $  4.83        242,500         $  4.09
                                   ==========      =========     =========        =========

                   Exercisable       39,069                       140,000
                                   ==========                    =========
</TABLE>

       The Company  realizes an income tax  benefit  from the  exercise or early
       disposition of certain stock options.  For financial  reporting purposes,
       the  tax  effect  of this  deduction  is  accounted  for an  increase  in
       additional  paid-in  capital,  rather than as a  reduction  of income tax
       expense.  A tax benefit of  approximately  $21,400 was recognized for the
       year ended July 31, 1998.

                                       6
<PAGE>
              FIRST AMERICAN HEALTH CONCEPTS, INC. AND SUBSIDIARIES

              Notes to Consolidated Financial Statements, Continued

(7)    EMPLOYEE STOCK OWNERSHIP PLAN

       The Company maintains an employee stock ownership plan (ESOP),  qualified
       as a stock bonus plan under Section 401(a) of the Internal  Revenue Code.
       The Plan is designed to invest primarily in Company stock exclusively for
       the benefit of eligible  employees  of the  Company.  Eligible  employees
       become participants in the Plan upon completion of one year of service as
       defined by the Plan.  Company  contributions  are determined each year by
       the Company's Board of Directors (subject to certain limitations) and are
       allocated among the accounts of participants in proportion to their total
       compensation.

       During fiscal 1995, the Trust borrowed $422,000 from a bank for a term of
       five years at an annual interest rate of 8.42%. The proceeds,  along with
       the  Company's  1994  ESOP  contribution,  were used to  purchase  91,978
       treasury shares from the Company.  Because the Company has guaranteed the
       bank loan,  it is reported as long-term  debt of the Company.  The shares
       sold by the Company to the Trust are reflected in  shareholders'  equity,
       and  an  amount  corresponding  to the  borrowing  (the  guaranteed  ESOP
       obligation) is reported as a reduction of shareholders'  equity.  At July
       31, 1998,  the fair market value of the 16,716  unearned  ESOP shares was
       $73,133.

       The loan agreement  requires quarterly payments of principal and interest
       which will be paid from the Company's  contributions  to the ESOP. As the
       principal  amount of the  borrowing  is  repaid,  the  liability  and the
       guaranteed   ESOP   obligation  are  reduced.   The  Company   recognizes
       compensation expense equal to the average fair market value of the shares
       committed  to be released for  allocation  to  participants  in the ESOP,
       which is based on total debt service requirements.  Such expense amounted
       to $59,951 for 1998 and $61,388 for 1997.

       Minimum  remaining  principal  payments required to be made during fiscal
       years ending July 31 are $84,400 in 1999 and $21,100 in 2000.


(8)    INCOME TAXES

       Components  of income tax  expense  for the years ended July 31, 1998 and
       1997 include:

                                  CURRENT        DEFERRED         TOTAL
                                ----------      ----------     ----------

       1998:
          Federal               $  (56,616)        245,565        188,948
          State                    (15,012)         65,112         50,100
                                ----------      ----------     ----------

                                $  (71,628)        310,677        239,049
                                ==========      ==========     ==========

       1997:
          Federal               $   84,000          62,000        146,000
          State                     22,000          16,000         38,000
                                ----------      ----------     ----------

                                $  106,000          78,000        184,000
                                ==========      ==========     ==========

                                       7
<PAGE>
              FIRST AMERICAN HEALTH CONCEPTS, INC. AND SUBSIDIARIES

              Notes to Consolidated Financial Statements, Continued

       Actual tax expense  differs from the "expected" tax expense  (computed by
       applying the applicable U.S. Federal  corporate tax rate of 34% to income
       before income taxes) as follows:

                                                              1998       1997
                                                            --------   --------
       Computed "expected" tax expense                      $200,521    163,000
       Increase (reduction) in income taxes resulting from:
           State income taxes, net of Federal benefit         33,066     25,000
       Other items                                             5,462     (4,000)
                                                            --------   --------

                                                            $239,049    184,000
                                                            ========   ========

       The  temporary  differences  that give rise to  deferred  tax  assets and
       liabilities at July 31, 1998 include:

       Deferred tax assets:
           Capital loss carryforward                         $ 169,403
           Accrued expenses                                     18,060
                                                             ---------
                  Total gross deferred tax assets              187,463

           Less valuation allowance                               --
                                                             ---------

                  Net deferred tax asset                       187,463
                                                             ---------

       Deferred tax liabilities:
           Deferred costs                                     (274,895)
           Accelerated depreciation                           (416,723)
                                                             ---------
                  Total gross deferred tax liabilities        (691,618)
                                                             ---------

                  Net deferred tax liability                 $(504,155)
                                                             =========

       In  assessing  the  realizability  of  deferred  tax  assets,  management
       considers  whether it is more likely than not that some portion or all of
       the deferred tax assets will not be  realized.  Accordingly,  the Company
       has determined that a valuation  allowance is not necessary and there was
       no change in the valuation allowance during the year ended July 31, 1998.

                                       8
<PAGE>
              FIRST AMERICAN HEALTH CONCEPTS, INC. AND SUBSIDIARIES

              Notes to Consolidated Financial Statements, Continued

(9)    BUSINESS SEGMENTS AND MAJOR CUSTOMERS

       The  Company's  operations  are in one business  segment  throughout  the
       United   States  -  the   development   and   marketing  of  vision  care
       cost-containment  programs.  One  customer  accounted  for 4% of revenues
       during fiscal 1998. During fiscal 1997, one customer  accounted for 10.5%
       of revenues.

       The Company operates in a very competitive  market. The Company's success
       is dependent upon the ability of its marketing  group, and its network of
       agents,  to identify  and  contract  with  businesses  and  organizations
       nationwide,  and to administer its networks. Changes in the insurance and
       health care industries,  including the regulation  thereof by federal and
       state agencies,  may significantly  affect management's  estimates of the
       Company's performance.

       The allowance for doubtful accounts is based on the  creditworthiness  of
       the Company's  customers as well as  consideration  for general  economic
       conditions. Consequently, an adverse change in those factors could affect
       the Company's estimate of its bad debts.


(10)   COMMITMENTS AND CONTINGENCIES

       The Company is subject to various  claims and  litigation  arising out of
       the  ordinary  course of  business.  In the  opinion of  management,  the
       Company has adequate legal defenses and the outcome of those matters will
       not materially effect the Company's financial position.

       Certain agreements with customer companies and networks are cancelable at
       the option of those  parties with written  notice which varies from 30 to
       90 days.  Management  generally attempts to renegotiate any such canceled
       agreements. Management believes that there is very little likelihood that
       there would be cancellations sufficient to have a material adverse effect
       on the Company's results of operations or financial condition.

       Management  has developed a plan to address the Year 2000 problem and all
       computer  systems  are in the  process  of  conversion  to be  Year  2000
       compliant. The Year 2000 problem is the result of computer programs being
       written using two digits rather than four digits to define the applicable
       year.  The total cost of the project is not  material  and the Company is
       expensing all associated costs as they are incurred.

                                       9
<PAGE>
                      FIRST AMERICAN HEALTH CONCEPTS, INC.
                              SCHEDULE OF EXHIBITS


- --------------------------------------------------------------------------------

27  Financial Data Schedule

28  Notice of Meeting and Proxy         Incorporated by reference to
    Statement                           the Company's 1998 Definitive
                                        Notice and Proxy Statement.
- --------------------------------------------------------------------------------

<TABLE> <S> <C>


<ARTICLE>                     5
<LEGEND>
THIS  SCHEDULE  CONTAINS  SUMMARY  FINANCIAL   INFORMATION  EXTRACTED  FROM  THE
CONSOLIDATED  FINANCIAL  STATEMENTS  FOR THE YEAR  ENDED  JULY  31,  1998 AND IS
QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS
</LEGEND>
<MULTIPLIER>                    1
<CURRENCY>                      U.S. DOLLARS
       
<S>                             <C>
<PERIOD-TYPE>                   YEAR
<FISCAL-YEAR-END>                                                   JUL-31-1998
<PERIOD-START>                                                      AUG-01-1997
<PERIOD-END>                                                        JUL-31-1998
<EXCHANGE-RATE>                                                               1
<CASH>                                                                1,342,759
<SECURITIES>                                                          1,002,158
<RECEIVABLES>                                                         1,424,316
<ALLOWANCES>                                                             37,870
<INVENTORY>                                                                   0
<CURRENT-ASSETS>                                                      4,843,226
<PP&E>                                                                3,759,457
<DEPRECIATION>                                                        1,759,087
<TOTAL-ASSETS>                                                        7,536,410
<CURRENT-LIABILITIES>                                                 2,235,225
<BONDS>                                                                       0
                                                         0
                                                                   0
<COMMON>                                                                681,546
<OTHER-SE>                                                            4,598,539
<TOTAL-LIABILITY-AND-EQUITY>                                          7,536,410
<SALES>                                                                       0
<TOTAL-REVENUES>                                                      7,809,122
<CGS>                                                                         0
<TOTAL-COSTS>                                                         7,366,233
<OTHER-EXPENSES>                                                       (163,164)
<LOSS-PROVISION>                                                              0
<INTEREST-EXPENSE>                                                       16,286
<INCOME-PRETAX>                                                         589,767
<INCOME-TAX>                                                            239,049
<INCOME-CONTINUING>                                                     589,767
<DISCONTINUED>                                                                0
<EXTRAORDINARY>                                                               0
<CHANGES>                                                                     0
<NET-INCOME>                                                            350,718
<EPS-PRIMARY>                                                              0.14
<EPS-DILUTED>                                                              0.14
        

</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission